+1 (646) 663-5829 | +91 702 496 8807

  sales@regionalresearchreports.com

Gynecological Cancers Therapeutics Market 2022 by Type, Sales Channel, Application, Regions, Company Share, Forecast to 2030

Publish Date: Mar 2024
Report ID:HC-1097
Base Year:2023
Report Format:PDF, Excel
Report Pages:187
Region:Global

Table of Content

  1. Global Gynecological Cancers Therapeutics Market Introduction and Market Overview
    1. Objective of the Study
    2. Global Gynecological Cancers Therapeutics Market Scope and Market Estimation
      1. Global Gynecological Cancers Therapeutics Overall Market Size (US$ Mn), Market CAGR (%), Market Forecast (2022-2030)
      2. Global Gynecological Cancers Therapeutics Market Revenue Share (%) and Growth Rate (Y-o-Y) from 2022-2030
    3. Market Segmentation
      1. Drug of Global Gynecological Cancers Therapeutics Market
      2. Route Of Administration of Global Gynecological Cancers Therapeutics Market
      3. Application of Global Gynecological Cancers Therapeutics Market
      4. Region of Global Gynecological Cancers Therapeutics Market
  2. Global Gynecological Cancers Therapeutics Market - Executive Summary
    1. Key Findings
      1. Top Impacting Factors
      2. Top Investment Pockets
      3. Market Attractiveness Analysis
    2. Key Companies Introduction
  3. Market Factor Analysis
    1. Global Gynecological Cancers Therapeutics Market Industry Development Trends under COVID-19 Outbreak
      1. Global COVID-19 Status Overview
      2. Influence of COVID-19 Outbreak on Global Gynecological Cancers Therapeutics Market Industry Development
    2. Market Dynamics (Growth Influencers)
      1. Drivers
      2. Restraints
      3. Opportunities
      4. Impact Analysis of Drivers and Restraints
    3. Ecosystem/ Value Chain Analysis
    4. Porter’s Five Forces Analysis
    5. SWOT Analysis
    6. PEST Analysis
    7. Market Opportunity Assessment – by Region (North America/ Europe/ Asia Pacific/ Middle East and Africa/ South America)
      1. By Drug
      2. By Route Of Administration
      3. By Application
  4. Global Gynecological Cancers Therapeutics Market: Estimates & Historic Trend Analysis (2017-2020)
  5. Global Gynecological Cancers Therapeutics Market Estimates & Forecast Trend Analysis, by Drug
    1. Gynecological Cancers Therapeutics Market Share (%) Estimates and Forecasts, by Drug, 2022 & 2030
      1. Key Market Trends, Growth Factors, and Opportunities
    2. Gynecological Cancers Therapeutics Market Revenue (US$ Mn) Estimates and Forecasts, by Drug, 2017 to 2030
      1. Key Market Trends, Growth Factors, and Opportunities
    3. Avastin
    4. Tecentriq
    5. Cometriq
    6. Eylea
  6. Global Gynecological Cancers Therapeutics Market Estimates & Forecast Trend Analysis, by Route Of Administration
    1. Gynecological Cancers Therapeutics Market Share (%) Estimates and Forecasts, by Route Of Administration, 2022 & 2030
      1. Key Market Trends, Growth Factors, and Opportunities
    2. Gynecological Cancers Therapeutics Market Revenue (US$ Mn) Estimates and Forecasts, by Route Of Administration, 2017 to 2030
      1. Key Market Trends, Growth Factors, and Opportunities
    3. Oral
    4. Intravenous
  7. Global Gynecological Cancers Therapeutics Market Estimates & Forecast Trend Analysis, by Application
    1. Gynecological Cancers Therapeutics Market Share (%) Estimates and Forecasts, by Application, 2022 & 2030
      1. Key Market Trends, Growth Factors, and Opportunities
    2. Gynecological Cancers Therapeutics Market Revenue (US$ Mn) Estimates and Forecasts, by Application, 2017 to 2030
      1. Key Market Trends, Growth Factors, and Opportunities
    3. Oncology
    4. Ophthalmology
    5. Others
  8. Global Gynecological Cancers Therapeutics Market Analysis and Forecast, by Region
    1. Gynecological Cancers Therapeutics Market Share (%) Estimates and Forecasts, by Region, 2022 & 2030
      1. Key Market Trends, Growth Factors, and Opportunities
    2. Gynecological Cancers Therapeutics Market Revenue (US$ Mn) Estimates and Forecasts, by Region, 2017 to 2030
      1. Key Market Trends, Growth Factors, and Opportunities
      2. North America
      3. Europe
      4. Asia Pacific
      5. Middle East and Africa
      6. South America
  9. North America Gynecological Cancers Therapeutics Market: Estimates & Forecast Trend Analysis
    1. North America Market Assessments & Key Findings
    2. North America Gynecological Cancers Therapeutics Market Share (%) Estimates and Forecasts, 2022 & 2030
    3. North America Gynecological Cancers Therapeutics Market Size Estimates and Forecast (US$ Million) (2017 to 2030)
      1. By Drug
      2. By Route Of Administration
      3. By Application
      4. By Country
        1. U.S.
        2. Canada
        3. Mexico
  10. Europe Gynecological Cancers Therapeutics Market: Estimates & Forecast Trend Analysis
    1. Europe Market Assessments & Key Findings
    2. Europe Gynecological Cancers Therapeutics Market Share (%) Estimates and Forecasts, 2022 & 2030
    3. Europe Gynecological Cancers Therapeutics Market Size Estimates and Forecast (US$ Million) (2017 to 2030)
      1. By Drug
      2. By Route Of Administration
      3. By Application
      4. By Country
        1. Germany
        2. U.K.
        3. France
        4. Italy
        5. Spain
        6. Russia
        7. Rest of Europe
  11. Asia Pacific Gynecological Cancers Therapeutics Market: Estimates & Forecast Trend Analysis
    1. Asia Pacific Market Assessments & Key Findings
    2. Asia Pacific Gynecological Cancers Therapeutics Market Share (%) Estimates and Forecasts, 2022 & 2030
    3. Asia Pacific Market Size Estimates and Forecast (US$ Million) (2017 to 2030)
      1. By Drug
      2. By Route Of Administration
      3. By Application
      4. By Country
        1. China
        2. Japan
        3. India
        4. Australia
        5. South Korea
        6. Rest of Asia Pacific
  12. Middle East & Africa Gynecological Cancers Therapeutics Market: Estimates & Forecast Trend Analysis
    1. Middle East & Africa Market Assessments & Key Findings
    2. Middle East & Africa Gynecological Cancers Therapeutics Market Share (%) Estimates and Forecasts, 2022 & 2030
    3. Middle East & Africa Market Size Estimates and Forecast (US$ Million) (2017 to 2030)
      1. By Drug
      2. By Route Of Administration
      3. By Application
      4. By Country
        1. U.A.E.
        2. Saudi Arabia
        3. Egypt
        4. South Africa
        5. Rest of Middle East & Africa
  13. South America Gynecological Cancers Therapeutics Market: Estimates & Forecast Trend Analysis
    1. South America Market Assessments & Key Findings
    2. South America Gynecological Cancers Therapeutics Market Share (%) Estimates and Forecasts, 2022 & 2030
    3. South America Market Size Estimates and Forecast (US$ Million) (2017 to 2030)
      1. By Drug
      2. By Route Of Administration
      3. By Application
      4. By Country
        1. Brazil
        2. Argentina
        3. Colombia
        4. Rest of South America
  14. Manufacturing Cost Structure Analysis
    1. Raw Material and Suppliers
    2. Manufacturing Cost Structure Analysis of Gynecological Cancers Therapeutics
    3. Manufacturing Process Analysis of Gynecological Cancers Therapeutics
    4. Industry Chain Structure of Gynecological Cancers Therapeutics
  15. Marketing, Distributors and Customer
    1. Sales Channel
      1. Direct Channels
      2. Indirect Channels
    2. Gynecological Cancers Therapeutics Distributors
    3. Gynecological Cancers Therapeutics Customer
  16. Competition Landscape
    1. Key Manufacturers Gynecological Cancers Therapeutics Producing Area Distribution, Sales Area, Product Drug
    2. Key Manufacturers Gynecological Cancers Therapeutics Product Location Distribution
    3. Market Competition Matrix, by Leading Players
      1. Competition Landscape Analysis
      2. Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    4. List of Emerging, Prominent and Leading Players
    5. Major Mergers & Acquisitions, Partnership, Joint Venture, Expansions, Deals, Etc.
  17. Company Profiles
    1. AbbVie Inc.
      1. Company Information
      2. Gynecological Cancers Therapeutics Product Offered
      3. Gynecological Cancers Therapeutics Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    2. Amgen Inc.
      1. Company Information
      2. Gynecological Cancers Therapeutics Product Offered
      3. Gynecological Cancers Therapeutics Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    3. AstraZeneca Plc
      1. Company Information
      2. Gynecological Cancers Therapeutics Product Offered
      3. Gynecological Cancers Therapeutics Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    4. Becton Dickinson and Co.
      1. Company Information
      2. Gynecological Cancers Therapeutics Product Offered
      3. Gynecological Cancers Therapeutics Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    5. Biocon Ltd.
      1. Company Information
      2. Gynecological Cancers Therapeutics Product Offered
      3. Gynecological Cancers Therapeutics Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    6. Bristol Myers Squibb Co.
      1. Company Information
      2. Gynecological Cancers Therapeutics Product Offered
      3. Gynecological Cancers Therapeutics Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    7. Clovis Oncology Inc.
      1. Company Information
      2. Gynecological Cancers Therapeutics Product Offered
      3. Gynecological Cancers Therapeutics Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    8. Daiichi Sankyo Co. Ltd.
      1. Company Information
      2. Gynecological Cancers Therapeutics Product Offered
      3. Gynecological Cancers Therapeutics Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    9. Eli Lilly and Co.
      1. Company Information
      2. Gynecological Cancers Therapeutics Product Offered
      3. Gynecological Cancers Therapeutics Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    10. F. Hoffmann La Roche Ltd.
      1. Company Information
      2. Gynecological Cancers Therapeutics Product Offered
      3. Gynecological Cancers Therapeutics Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    11. GlaxoSmithKline Plc
      1. Company Information
      2. Gynecological Cancers Therapeutics Product Offered
      3. Gynecological Cancers Therapeutics Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    12. ImmunoGen Inc.
      1. Company Information
      2. Gynecological Cancers Therapeutics Product Offered
      3. Gynecological Cancers Therapeutics Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    13. Johnson and Johnson
      1. Company Information
      2. Gynecological Cancers Therapeutics Product Offered
      3. Gynecological Cancers Therapeutics Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    14. Karyopharm Therapeutics Inc.
      1. Company Information
      2. Gynecological Cancers Therapeutics Product Offered
      3. Gynecological Cancers Therapeutics Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    15. Merck and Co. Inc.
      1. Company Information
      2. Gynecological Cancers Therapeutics Product Offered
      3. Gynecological Cancers Therapeutics Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    16. Novartis AG
      1. Company Information
      2. Gynecological Cancers Therapeutics Product Offered
      3. Gynecological Cancers Therapeutics Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    17. Pfizer Inc.
      1. Company Information
      2. Gynecological Cancers Therapeutics Product Offered
      3. Gynecological Cancers Therapeutics Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
    18. Sanofi
      1. Company Information
      2. Gynecological Cancers Therapeutics Product Offered
      3. Gynecological Cancers Therapeutics Sales, Revenue, Price, and Gross Margin (2018-2022)
      4. Main Business Overview
      5. Latest Developments
  18. Assumptions and Research Methodology
  19. Conclusions and Recommendations
    1. Analysis and Suggestions on New Project Investment
    2. Research Findings and Conclusion

List of Tables

  1. Global Gynecological Cancers Therapeutics Market Historic Analysis (US$ Mn), 2017-2021
  2. Global Gynecological Cancers Therapeutics Market Forecast Opportunity Analysis (US$ Mn), 2022-2030
  3. Global Gynecological Cancers Therapeutics Market Absolute $ Opportunity
  4. Global Gynecological Cancers Therapeutics Market Analysis by Drug, 2017-2030
  5. Global Gynecological Cancers Therapeutics Market Analysis by Route Of Administration, 2017-2030
  6. Global Gynecological Cancers Therapeutics Market Analysis by Application, 2017-2030
  7. Global Gynecological Cancers Therapeutics Market Analysis by Region, 2017-2030
  8. North America Gynecological Cancers Therapeutics Market Absolute $ Opportunity
  9. North America Gynecological Cancers Therapeutics Market Analysis by Drug, 2017-2030
  10. North America Gynecological Cancers Therapeutics Market Analysis by Route Of Administration, 2017-2030
  11. North America Gynecological Cancers Therapeutics Market Analysis by Application, 2017-2030
  12. North America Gynecological Cancers Therapeutics Market Analysis by Country, 2017-2030
  13. South America Gynecological Cancers Therapeutics Market Absolute $ Opportunity
  14. South America Gynecological Cancers Therapeutics Market Analysis by Drug, 2017-2030
  15. South America Gynecological Cancers Therapeutics Market Analysis by Route Of Administration, 2017-2030
  16. South America Gynecological Cancers Therapeutics Market Analysis by Application, 2017-2030
  17. South America Gynecological Cancers Therapeutics Market Analysis by Country, 2017-2030
  18. Europe Gynecological Cancers Therapeutics Market Absolute $ Opportunity
  19. Europe Gynecological Cancers Therapeutics Market Analysis by Drug, 2017-2030
  20. Europe Gynecological Cancers Therapeutics Market Analysis by Route Of Administration, 2017-2030
  21. Europe Gynecological Cancers Therapeutics Market Analysis by Application, 2017-2030
  22. Europe Gynecological Cancers Therapeutics Market Analysis by Country, 2017-2030
  23. Asia Pacific Gynecological Cancers Therapeutics Market Absolute $ Opportunity
  24. Asia Pacific Gynecological Cancers Therapeutics Market Analysis by Drug, 2017-2030
  25. Asia Pacific Gynecological Cancers Therapeutics Market Analysis by Route Of Administration, 2017-2030
  26. Asia Pacific Gynecological Cancers Therapeutics Market Analysis by Application, 2017-2030
  27. Asia Pacific Gynecological Cancers Therapeutics Market Analysis by Country, 2017-2030
  28. MEA Gynecological Cancers Therapeutics Market Absolute $ Opportunity
  29. MEA Gynecological Cancers Therapeutics Market Analysis by Drug, 2017-2030
  30. MEA Gynecological Cancers Therapeutics Market Analysis by Route Of Administration, 2017-2030
  31. MEA Gynecological Cancers Therapeutics Market Analysis by Application, 2017-2030
  32. MEA Gynecological Cancers Therapeutics Market Analysis by Country, 2017-2030

List of Figures

  1. Global Gynecological Cancers Therapeutics Market Historic Y-o-Y Analysis (%), 2017-2021
  2. Global Gynecological Cancers Therapeutics Market Forecast Y-o-Y Analysis (%), 2022-2030
  3. Global Gynecological Cancers Therapeutics Market Share Analysis by Drug, 2021 and 2030
  4. Global Gynecological Cancers Therapeutics Market Share Analysis by Route Of Administration, 2021 and 2030
  5. Global Gynecological Cancers Therapeutics Market Share Analysis by Application, 2021 and 2030
  6. Global Gynecological Cancers Therapeutics Market Share Analysis by Region, 2021 and 2030
  7. North America Gynecological Cancers Therapeutics Market Share Analysis by Drug, 2021 and 2030
  8. North America Gynecological Cancers Therapeutics Market Share Analysis by Route Of Administration, 2021 and 2030
  9. North America Gynecological Cancers Therapeutics Market Share Analysis by Application, 2021 and 2030
  10. North America Gynecological Cancers Therapeutics Market Share Analysis by Country, 2021 and 2030
  11. South America Gynecological Cancers Therapeutics Market Share Analysis by Drug, 2021 and 2030
  12. South America Gynecological Cancers Therapeutics Market Share Analysis by Route Of Administration, 2021 and 2030
  13. South America Gynecological Cancers Therapeutics Market Share Analysis by Application, 2021 and 2030
  14. South America Gynecological Cancers Therapeutics Market Share Analysis by Country, 2021 and 2030
  15. Europe Gynecological Cancers Therapeutics Market Share Analysis by Drug, 2021 and 2030
  16. Europe Gynecological Cancers Therapeutics Market Share Analysis by Route Of Administration, 2021 and 2030
  17. Europe Gynecological Cancers Therapeutics Market Share Analysis by Application, 2021 and 2030
  18. Europe Gynecological Cancers Therapeutics Market Share Analysis by Country, 2021 and 2030
  19. Asia Pacific Gynecological Cancers Therapeutics Market Share Analysis by Drug, 2021 and 2030
  20. Asia Pacific Gynecological Cancers Therapeutics Market Share Analysis by Route Of Administration, 2021 and 2030
  21. Asia Pacific Gynecological Cancers Therapeutics Market Share Analysis by Application, 2021 and 2030
  22. Asia Pacific Gynecological Cancers Therapeutics Market Share Analysis by Country, 2021 and 2030
  23. MEA Gynecological Cancers Therapeutics Market Share Analysis by Drug, 2021 and 2030
  24. MEA Gynecological Cancers Therapeutics Market Share Analysis by Route Of Administration, 2021 and 2030
  25. MEA Gynecological Cancers Therapeutics Market Share Analysis by Application, 2021 and 2030
  26. MEA Gynecological Cancers Therapeutics Market Share Analysis by Country, 2021 and 2030
    market statsville report image

    Want to Review Complete Market Research Report

    Request Sample
    $3150  $2450 save 23%
    $4950  $3850 save 25%
    $7680  $5100 save 30%
    Buy Chapters or Sections

    Avail customized purchase options to meet your exact research needs:

    • Buy sections of this report
    • Buy country level reports
    • Request for historical data
    • Request discounts available for Start-Ups & Universities

    Budget constrains? Get in touch with us for special pricing
    Request Discount

    Phone: +1 (888) 615 4898

    Email: sales@regionalresearchreports.com

    Chat with Us: Click here to start